Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| J. Edwards | M | 57 |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 1 years |
| Hollings Renton | M | 77 |
Cetus Corp.
| 8 years |
| William J. Brock | M | 74 | 9 years | |
| Kathy Ordoñez | F | 73 |
Roche Molecular Systems, Inc.
 Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | 9 years |
| Glenn C. Rice | M | 68 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 3 years |
| Richard L. Love | M | 81 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 10 years |
| S. Mark Poler | M | 71 |
The University of California, San Francisco
| 7 years |
| Robert A. Fildes | M | 85 |
Cetus Corp.
| - |
| Alexander Ruckdaeschel | M | 52 | 9 years | |
| Alexander L. Weis | M | 74 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 4 years |
| Tom Kuh | M | - |
Hampshire College
| 2 years |
| James Carman Wemett | M | 75 | 3 years | |
| Thomas J. White | M | 78 |
Cetus Corp.
| 11 years |
| Charles J. Betlach | M | - |
The University of California, San Francisco
| 3 years |
| John P. Thurber | M | 69 |
Hampshire College
| 4 years |
| Behzad Khosrovi | M | 80 |
Cetus Corp.
| 14 years |
| Richard Carmona | M | 74 |
The University of California, San Francisco
| 3 years |
| Allen Dudley Shepard | M | - |
Hampshire College
| 4 years |
| Jeffrey Kang | M | - |
The University of California, San Francisco
| 3 years |
| Scott Kurnit | M | 70 |
Hampshire College
| 4 years |
| David Gelfand | M | 79 |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | 14 years |
| Peter Farley | M | - |
Cetus Corp.
| 14 years |
| Guido Baechler | M | 59 |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | 12 years |
| Mitchell Golbus | M | - |
The University of California, San Francisco
| 13 years |
| Natalie R. Cohen | F | - |
Hampshire College
| 2 years |
| Bob Frazier | M | - |
The University of California, San Francisco
| 4 years |
| Jeff Koblick | M | - |
The University of California, San Francisco
| 3 years |
| Michael Sutherland | M | - |
Hampshire College
| - |
| Walter Greenleaf | M | - |
Hampshire College
| 4 years |
| Barry Sonnenfeld | M | 71 |
Hampshire College
| 3 years |
| David Schwartz | M | - |
Hampshire College
| 4 years |
| Fouad Jwayed Qassem Al-Sherebi | M | - |
The University of California, San Francisco
| 4 years |
| W. Dorsey Stuart | M | - |
Cetus Corp.
| 2 years |
| Michael Goldberg | M | 66 |
Cetus Corp.
| 4 years |
| Richard L. Bedell | M | 68 |
Hampshire College
| 4 years |
| William G. Gerber | M | 77 |
Cetus Corp.
| - |
| Mark P. Mellin | M | 62 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 4 years |
| Francis McCormick | M | 73 |
Cetus Corp.
| 11 years |
| Terry Murdock | M | 64 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 11 years |
| Josefina T. Elchico | F | 77 |
Cetus Corp.
| 7 years |
| Larry Rosenfeld | M | 71 |
Hampshire College
| 4 years |
| James Crown | M | 70 |
Hampshire College
| 4 years |
| Joy Amundson | F | 69 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 2 years |
| Peter Staple | M | 72 |
Cetus Corp.
| 8 years |
| Julian N. Stern | M | 99 |
Cetus Corp.
| - |
| William J. Rutter | M | - |
The University of California, San Francisco
| 10 years |
| Eric M. Ruttenberg | M | 68 |
Hampshire College
| 5 years |
| Gregory Weaver | M | 68 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 3 years |
| Brian C. Keller | M | 68 |
The University of California, San Francisco
| 3 years |
| Jeffrey H. Buchalter | M | 67 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 3 years |
| Michael S. Ostrach | M | 72 |
Cetus Corp.
| 10 years |
| Frank Kung | M | 75 |
Cetus Corp.
| 2 years |
| Glenn Sblendorio | M | 68 |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | 1 years |
| Scott D. Kelley | M | 65 |
The University of California, San Francisco
| 3 years |
| Peter Palmedo | M | 68 |
Hampshire College
| 4 years |
| David C. Kaslow | M | 65 |
The University of California, San Francisco
| 3 years |
| Timothy M. Ruane | M | 59 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 4 years |
| Craig Tooman | M | 58 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 3 years |
| Andrea W. Tobias | M | - |
The University of California, San Francisco
| 5 years |
| Hing Wong | M | 70 |
Cetus Corp.
| 9 years |
| Drubin David | M | - |
The University of California, San Francisco
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 61 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Corey Levenson
- Personal Network
